Legal & General Group
BNTC icon

Legal & General Group’s Benitec Biopharma BNTC Stock Holding History

Legal & General Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5K Buy
2,131
+385
+22% +$4.57K ﹤0.01% 2971
2026
Q1 		$18.6K Buy
1,746
+214
+14% +$2.48K ﹤0.01% 2985
2025
Q4 		$20.6K Sell
1,532
-81
-5% -$1.12K ﹤0.01% 3014
2025
Q3 		$22.6K Hold
1,613
– – ﹤0.01% 2996
2025
Q2 		$18.9K Buy
+1,613
New +$22.6K ﹤0.01% 3027

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Legal & General Group's BNTC Position: Q2 2026 in Review

Legal & General Group increased its Benitec Biopharma (BNTC) stake by 22% in Q2 2026, buying an estimated $4.57K and bringing the position to 2,131 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2971.

Legal & General Group first reported a position in BNTC in Q2 2025 and has held it in 5 quarters since. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Legal & General Group held 2,131 shares of Benitec Biopharma worth $28.5K as of Q2 2026.
  • Legal & General Group bought 385 Benitec Biopharma shares in Q2 2026, an estimated $4.57K.
  • Benitec Biopharma made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2971 holding.
  • Legal & General Group first reported a position in Benitec Biopharma in Q2 2025 and has held it in 5 quarters since.
  • 86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.